{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:46:40Z","timestamp":1746334000378,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12969-019-0352-3","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T09:03:00Z","timestamp":1564563780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Sama","family":"Samadli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goshgar","family":"Mammadov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang Huang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2144-9806","authenticated-orcid":false,"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"352_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2017.05.019","volume":"471","author":"P Hu","year":"2017","unstructured":"Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, et al. TNF-\u03b1 is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease. Clin Chim Acta. 2017;471:76\u201380.","journal-title":"Clin Chim Acta"},{"key":"352_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/INF.0000000000000914","volume":"35","author":"JJ Chen","year":"2016","unstructured":"Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M, et al. Shanghai Kawasaki disease research group. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Dis J. 2016;35:7\u201312.","journal-title":"Pediatr Infect Dis J"},{"key":"352_CR3","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927\u201399.","journal-title":"Circulation"},{"key":"352_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jcla.20414","volume":"24","author":"S Xiu-Yu","year":"2010","unstructured":"Xiu-Yu S, Jia-Yu H, Qiang H, Shu-Hui D. Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis. J Clin Lab Anal. 2010;24:385\u20138.","journal-title":"J Clin Lab Anal"},{"key":"352_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0735-1097(86)80505-8","volume":"7","author":"TE Capannari","year":"1986","unstructured":"Capannari TE, Daniels SR, Meyer RA, Schwartz DC, Kaplan S. Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol. 1986;7:355\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"352_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341\u20137.","journal-title":"N Engl J Med"},{"key":"352_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/00325481.2018.1468712","volume":"130","author":"H Qiu","year":"2018","unstructured":"Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, et al. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status. Postgrad Med. 2018;130:442\u20137.","journal-title":"Postgrad Med"},{"key":"352_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/archdischild-2012-302841","volume":"99","author":"D Eleftheriou","year":"2014","unstructured":"Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child. 2014;99:74\u201383.","journal-title":"Arch Dis Child"},{"key":"352_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3892\/etm.2015.2487","volume":"10","author":"H Zhu","year":"2015","unstructured":"Zhu H, Yu SF, Bai YX, Liang YY, Su XW, Pan JY. Kawasaki disease in children: epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years. Exp Ther Med. 2015;10:357\u201361.","journal-title":"Exp Ther Med"},{"key":"352_CR10","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41598-019-39330-y","volume":"9","author":"XH Tan","year":"2019","unstructured":"Tan XH, Zhang XW, Wang XY, He XQ, Fan C, Lyu TW, Tian J. A new model for predicting intravenous immunoglobin-resistant Kawasaki disease in Chongqing: a retrospective study on 5277 patients. Sci Rep. 2019;9:1722.","journal-title":"Sci Rep"},{"key":"352_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10067-018-4393-7","volume":"38","author":"W Hua","year":"2019","unstructured":"Hua W, Ma F, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F. A new scoring system to predict Kawasaki disease with coronary artery lesions. Clin Rheumatol. 2019;38:1099\u2013107.","journal-title":"Clin Rheumatol"},{"key":"352_CR12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3892\/etm.2016.3393","volume":"12","author":"X Zhang","year":"2016","unstructured":"Zhang X, Liang Y, Feng W, Su X, Zhu H. Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013. Exp Ther Med. 2016;12:1220\u20134.","journal-title":"Exp Ther Med"},{"key":"352_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00246-011-0121-7","volume":"33","author":"X Zhang","year":"2012","unstructured":"Zhang X, Zhang Z, Liu S, Sun J. Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008. Pediatr Cardiol. 2012;33:272\u20139.","journal-title":"Pediatr Cardiol"},{"key":"352_CR14","first-page":"210382","volume":"2012","author":"HC Liu","year":"2012","unstructured":"Liu HC, Lo CW, Hwang B, Lee PC. Clinical manifestations vary with different age spectrums in infants with Kawasaki disease. ScientificWorldJournal. 2012;2012:210382.","journal-title":"ScientificWorldJournal"},{"key":"352_CR15","doi-asserted-by":"crossref","first-page":"54357","DOI":"10.18632\/oncotarget.17530","volume":"8","author":"L Bai","year":"2017","unstructured":"Bai L, Feng T, Yang L, Zhang Y, Jiang X, Liao J, et al. Retrospective analysis of risk factors associated with Kawasaki disease in China. Oncotarget. 2017;8:54357\u201363.","journal-title":"Oncotarget"},{"key":"352_CR16","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606\u201312.","journal-title":"Circulation."},{"key":"352_CR17","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1542\/peds.2004-2182","volume":"114","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708\u201333.","journal-title":"Pediatrics"},{"key":"352_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0022-3476(05)83532-2","volume":"122","author":"TP Klassen","year":"1993","unstructured":"Klassen TP, Rowe PC, Gafni A. Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome. J Pediatr. 1993;122:538\u201342.","journal-title":"J Pediatr"},{"key":"352_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pedneo.2013.11.007","volume":"55","author":"AK Bal","year":"2014","unstructured":"Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease. Pediatr Neonatol. 2014;55:387\u201392.","journal-title":"Pediatr Neonatol"},{"key":"352_CR20","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/art.24660","volume":"60","author":"AC Lau","year":"2009","unstructured":"Lau AC, Duong TT, Ito S, Yeung RS. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease. Arthritis Rheum. 2009;60:2131\u201341.","journal-title":"Arthritis Rheum"},{"key":"352_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMoa061235","volume":"356","author":"JW Newburger","year":"2007","unstructured":"Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663\u201375.","journal-title":"N Engl J Med"},{"key":"352_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/gene.2014.47","volume":"15","author":"A Shendre","year":"2014","unstructured":"Shendre A, Wiener HW, Zhi D, Vazquez AI, Portman MA, Shrestha S. High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study. Genes Immun. 2014;15:534\u201342.","journal-title":"Genes Immun"},{"key":"352_CR23","doi-asserted-by":"publisher","first-page":"R261","DOI":"10.1186\/gb-2007-8-12-r261","volume":"8","author":"SJ Popper","year":"2007","unstructured":"Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol. 2007;8:R261.","journal-title":"Genome Biol"},{"key":"352_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/ped.13512","volume":"60","author":"Y Shiozawa","year":"2018","unstructured":"Shiozawa Y, Inuzuka R, Shindo T, Mafune R, Hayashi T, Hirata Y, et al. Effect of i.v. immunoglobulin in the first 4 days of illness in Kawasaki disease. Pediatr Int. 2018;60:334\u201341.","journal-title":"Pediatr Int"},{"key":"352_CR25","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/INF.0b013e31822d4f56","volume":"30","author":"AH Tremoulet","year":"2011","unstructured":"Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, Burns JC. Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J. 2011;30:1022\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"352_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3346\/jkms.2004.19.4.501","volume":"19","author":"KY Lee","year":"2004","unstructured":"Lee KY, Han JW, Hong JH, Lee HS, Lee JS, Whang KT. Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever. J Korean Med Sci. 2004;19:501\u20134.","journal-title":"J Korean Med Sci"},{"key":"352_CR27","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1542\/peds.2009-0606","volume":"125","author":"ES Yellen","year":"2010","unstructured":"Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125:e234\u201341.","journal-title":"Pediatrics"},{"key":"352_CR28","first-page":"S1875","volume":"30592-2","author":"YC Liu","year":"2018","unstructured":"Liu YC, Lin MT, Wang JK, Wu MH. State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association. Pediatr Neonato. 2018;30592-2:S1875\u20139572.","journal-title":"Pediatr Neonato"},{"key":"352_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1179\/1465328111Y.0000000005","volume":"31","author":"R Sittiwangkul","year":"2011","unstructured":"Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C. Delayed diagnosis of Kawasaki disease: risk factors and outcome of treatment. Ann Trop Paediatr. 2011;31:109\u201314.","journal-title":"Ann Trop Paediatr"},{"key":"352_CR30","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/eji.201242398","volume":"42","author":"A Matsuda","year":"2012","unstructured":"Matsuda A, Morita H, Unno H, Saito H, Matsumoto K, Hirao Y, et al. Anti-inflammatory effects of high-dose IgG on TNF-\u03b1-activated human coronary artery endothelial cells. Eur J Immunol. 2012;42:2121\u201331.","journal-title":"Eur J Immunol"},{"key":"352_CR31","first-page":"149","volume":"31","author":"L Masi","year":"2013","unstructured":"Masi L, Franceschelli F, Leoncini G, Gozzini A, Rigante D, La Torre F, et al. Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin Exp Rheumatol. 2013;31:149\u201353.","journal-title":"Clin Exp Rheumatol"},{"key":"352_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/CIRCGENETICS.110.940858","volume":"4","author":"C Shimizu","year":"2011","unstructured":"Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, et al. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet. 2011;4:16\u201325.","journal-title":"Circ Cardiovasc Genet"},{"key":"352_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1161\/CIRCGENETICS.116.001533","volume":"9","author":"C Shimizu","year":"2016","unstructured":"Shimizu C, Eleftherohorinou H, Wright VJ, Kim J, Alphonse MP, Perry JC, et al. Genetic variation in the SLC8A1 calcium signaling pathway is associated with susceptibility to Kawasaki disease and coronary artery abnormalities. Circ Cardiovasc Genet. 2016;9:559\u201368.","journal-title":"Circ Cardiovasc Genet"},{"key":"352_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpeds.2017.03.025","volume":"185","author":"AP Salgado","year":"2017","unstructured":"Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr. 2017;185:112\u20136.","journal-title":"J Pediatr"},{"key":"352_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/tropej\/fmv077","volume":"62","author":"Y Tang","year":"2016","unstructured":"Tang Y, Gao X, Shen J, Sun L, Yan W. Epidemiological and clinical characteristics of Kawasaki disease and factors associated with coronary artery abnormalities in East China: nine years experience. J Trop Pediatr. 2016;62:86\u201393.","journal-title":"J Trop Pediatr"},{"key":"352_CR36","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1542\/peds.2011-1704","volume":"129","author":"H Muta","year":"2012","unstructured":"Muta H, Ishii M, Yashiro M, Uehara R, Nakamura Y. Late intravenous immunoglobulin treatment in patients with Kawasaki disease. Pediatrics. 2012;129:e291\u20137.","journal-title":"Pediatrics"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0352-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-019-0352-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0352-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T22:23:25Z","timestamp":1664058205000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0352-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1186\/s12969-019-0352-3","relation":{},"ISSN":["1546-0096"],"issn-type":[{"type":"electronic","value":"1546-0096"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"6 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Research Ethics Commission of the First Affiliated Hospital of Anhui Medical University. Permission to carry out the study and access patient records was sought from the respective hospital administrators.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}